View Entire Collection
By Clinical Topic
Diabetes – Summer 2012
Future of Nursing Initiative
Heart Failure - Fall 2011
Influenza - Winter 2011
Nursing Ethics - Fall 2011
Trauma - Fall 2010
Traumatic Brain Injury - Fall 2010
Fluids & Electrolytes
An international panel of researchers recommends that patients with neuropathic pain receive any of five first-line drugs for initial pain control: an opioid, tricyclic antidepressant, gabapentin, topical lidocaine, or tramadol.
Participants in the Fourth International Conference on the Mechanisms and Treatment of Neuropathic Pain reviewed published information to devise treatment recommendations for people with neuropathic pain. Their guidelines, published in the Archives of Neurology, also review sequential and combination therapy with first-line drugs and the benefits and risks of second-line medications (other anticonvulsant medications and antidepressants).
As many as 50% of primary care providers consider nonsteroidal anti-inflammatory drugs (NSAIDs) a first-line treatment for neuropathic pain, researchers report, even though NSAIDs aren't effective for neuropathic pain and carry a significant risk of adverse reactions. When choosing a drug, health care providers should consider its efficacy, cost, adverse effects, ease of use, and interactions with other drugs. Those who lack expertise in treating neuropathic pain should refer patients to another practitioner with skill in pain assessment and treatment, such as a neurologist or anesthesiologist.
Advances in Neuropathic Pain," Archives of Neurology, R. Dworkin, et al., November 2003.
Sign up for our free enewsletters to stay up-to-date in your area of practice - or take a look at an archive of prior issues
Join our CESaver program to earn up to 100 contact hours for only $34.95
Explore a world of online resources
Back to Top